Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT02651870
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 135 participants
- Registry
-
NCT02651870
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02651870. Randomized; double masking; primary purpose treatment. Start 2015-04-22 (actual); primary completion 2016-02-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
- Condition
- Hypertension
- Intervention (Drug)
- Candesartan 16mg
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Drug)
- Amlodipine 10mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct02651870- Content hash
bf33819d0516029733f2388c52fd3e621bb27aa8197f86a6f48d22af0e90aaa2